INtRON Biotechnology Valuation
| 048530 Stock | KRW 3,840 30.00 0.78% |
At this time, the firm appears to be overvalued. iNtRON Biotechnology retains a regular Real Value of W3677.1 per share. The prevalent price of the firm is W3840.0. Our model calculates the value of iNtRON Biotechnology from evaluating the firm fundamentals such as Return On Equity of 11.16, return on asset of 0.0519, and Current Valuation of 734.71 B as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that INtRON Biotechnology's price fluctuation is very steady at this time. Calculation of the real value of iNtRON Biotechnology is based on 3 months time horizon. Increasing INtRON Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since INtRON Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of INtRON Stock. However, INtRON Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3840.0 | Real 3677.1 | Hype 3840.0 |
The real value of INtRON Stock, also known as its intrinsic value, is the underlying worth of iNtRON Biotechnology Company, which is reflected in its stock price. It is based on INtRON Biotechnology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of INtRON Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of iNtRON Biotechnology helps investors to forecast how INtRON stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of INtRON Biotechnology more accurately as focusing exclusively on INtRON Biotechnology's fundamentals will not take into account other important factors: INtRON Biotechnology Total Value Analysis
iNtRON Biotechnology is presently forecasted to have takeover price of 734.71 B with market capitalization of 265.62 B, debt of 16.13 B, and cash on hands of 75.17 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the INtRON Biotechnology fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
734.71 B | 265.62 B | 16.13 B | 75.17 B |
INtRON Biotechnology Investor Information
About 16.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 313.17. iNtRON Biotechnology had not issued any dividends in recent years. The entity had 2:1 split on the 10th of January 2019. Based on the key measurements obtained from INtRON Biotechnology's financial statements, iNtRON Biotechnology is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.INtRON Biotechnology Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. INtRON Biotechnology has an asset utilization ratio of 19.11 percent. This suggests that the Company is making W0.19 for each dollar of assets. An increasing asset utilization means that iNtRON Biotechnology is more efficient with each dollar of assets it utilizes for everyday operations.INtRON Biotechnology Ownership Allocation
iNtRON Biotechnology has a total of 29.88 Million outstanding shares. INtRON Biotechnology retains 15.72 (percent) of its outstanding shares held by insiders and 8.1 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.INtRON Biotechnology Profitability Analysis
The company reported the revenue of 29.31 B. Net Income was 9.73 B with profit before overhead, payroll, taxes, and interest of 26.45 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates INtRON Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in INtRON Biotechnology and how it compares across the competition.
About INtRON Biotechnology Valuation
The stock valuation mechanism determines INtRON Biotechnology's current worth on a weekly basis. Our valuation model uses a comparative analysis of INtRON Biotechnology. We calculate exposure to INtRON Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of INtRON Biotechnology's related companies.iNtRON Biotechnology, Inc., a biotechnology company, develops bacterial bio-drugs for the treatment of infectious diseases. In addition, the company develops drugs targeting functional moieties, including axakacin, pterostilbene, methylated flavonoid, etc. for use in silver and brain industries. iNtRON Biotechnology, Inc. was founded in 1999 and is headquartered in Seongnam, South Korea. iNtRON Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct INtRON Biotechnology's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates INtRON Biotechnology's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct INtRON Biotechnology's valuation analysis, follow these 8 steps:- Gather financial information: Obtain INtRON Biotechnology's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine INtRON Biotechnology's revenue streams: Identify INtRON Biotechnology's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research INtRON Biotechnology's industry and market trends, including the size of the market, growth rate, and competition.
- Establish INtRON Biotechnology's growth potential: Evaluate INtRON Biotechnology's management, business model, and growth potential.
- Determine INtRON Biotechnology's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate INtRON Biotechnology's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for INtRON Stock analysis
When running INtRON Biotechnology's price analysis, check to measure INtRON Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INtRON Biotechnology is operating at the current time. Most of INtRON Biotechnology's value examination focuses on studying past and present price action to predict the probability of INtRON Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INtRON Biotechnology's price. Additionally, you may evaluate how the addition of INtRON Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |